Clinical trial
A Prospective Multicenter Trial Evaluating the Safety and Effectiveness of Eso-SPONGE for the Treatment of Anastomotic Leaks in the Upper Gastrointestinal Tract
NCT07711093 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Trial Evaluating the Safety and Effectiveness of Eso-SPONGE for the Treatment of Anastomotic Leaks in the Upper Gastrointestinal Tract
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- April 30, 2029
- Enrollment
- 74 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anastomotic leaks